Global Immunoassay Market Research Analysis 2033
According to the report, the immunoassay market was valued at $35.0 billion in 2023, and is estimated to reach $61.6 billion by 2033, growing at a CAGR of 5.8% from 2024 to 2033.
Prime determinants of growth
Rise in incidences of chronic diseases, favorable regulatory scenario, and increase in geriatric population are the major factors that drive the growth of the immunoassay market growth. However, high development and manufacturing costs hinder market growth. Moreover, technological advancements and untapped markets in developing economies offer remunerative opportunities for the expansion of the global immunoassay market.
Key Takeaways
- The immunoassay market share study covers 20 countries. The research includes a segment analysis of each country in terms of value for the projected period.
- More than 1, 500 product literatures, industry releases, annual reports, and other such documents of major immunoassay industry participants along with authentic industry journals, trade associations’ releases, and government websites have been reviewed for generating high-value industry insights.
- The study integrated high-quality data, professional opinions and analysis, and critical independent perspectives. The research approach is intended to provide a balanced view of global markets and to assist stakeholders in making educated decisions in order to achieve their most ambitious growth objectives.
Segment Highlights
The enzyme-Linked Immunosorbent Assay (ELISA) segment to maintain its leadership status during the forecast period
By technology, the enzyme-Linked Immunosorbent Assay (ELISA) segment generated the highest revenue in the immunoassay market in 2023. The high sensitivity, specificity, and versatility of Enzyme-Linked Immunosorbent Assay (ELISA) , making it suitable for various applications. ELISA is valuable in medical diagnostics, research, and drug development due to its high sensitivity, specificity, and scalability. It plays a crucial role in diagnosing diseases, monitoring biomarkers, and evaluating immune responses, contributing to advancements in healthcare and biomedical research.
The blood specimen segment to maintain its leadership status during the forecast period
By specimen, the blood specimens segment generated the highest revenue in the immunoassay market in 2023. Blood specimens are widely used in immunoassays due to their accessibility, abundance of biomarkers, and ability to provide valuable insights into various diseases and conditions. Blood-based immunoassays enable the detection and quantification of specific analytes, such as proteins, antibodies, and hormones, facilitating disease diagnosis, prognosis, and monitoring.
The hospitals and clinics segment to maintain its leadership status during the forecast period
By end user, hospitals and clinics widely utilize immunoassay technology due to its versatility, accuracy, and rapid results. Immunoassays enable healthcare providers to perform a wide range of diagnostic tests, including disease screening, monitoring, and prognosis, enhancing patient care and treatment decision-making within clinical settings.
For Purchase Related Queries/Inquiry – https://www.alliedmarketresearch.com/purchase-enquiry/939
Regional Outlook
In North America there is a robust market for immunoassay due to advanced healthcare systems, rise in prevalence of chronic disease conditions, and greater accessibility to healthcare services. These regions also witness significant research and development activities, leading to the advancement in immunoassay technology. In emerging markets such as Asia-Pacific and LAMEA the immunoassay market is experiencing rapid growth driven by increasing healthcare expenditure and expanding pharmaceutical industries.
Key Players
- F. Hoffmann-La Roche Ltd.
- Danaher Corporation
- Abbott Laboratories
- Siemens Healthineers (Siemens AG)
- DiaSorin S.p.A.
- Sysmex Corporation
- BioMerieux SA
- Ortho Clinical Diagnostics
- Thermo Fisher Scientific, Inc.,
- Becton, Dickinson and Company
- Merck kGaA
Read More:
Sleep Apnea Implants Market Set for Robust Growth Through 2031
Global Plasma Fractionation Market Expands with Rising Demand for Immunoglobulins
Contact Details:
David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
